| Theme | Intraductal Papillary Mucinous Neoplasm (IPMN) | |
|---|---|---|
| Title | Surgical Treatment of Pancreatic Intraductal Papillary Mucinous Neoplasms | |
| Publish Date | 2009/08 | |
| Author | Takashi Hatori | Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author | Akira Kimijima | Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author | Izumi Fujita | Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author | Toru Furukawa | International Research and Educational Institute for Integrated Medical Sciences, Tokyo Women's Medical University |
| Author | Toshihide Imaizumi | Department of Surgery, School of Medicine, Tokai University |
| Author | Masakazu Yamamoto | Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| [ Summary ] | In the selection of surgical procedures which should be performed for intraductal papillary mucinous neoplasms (IPMN) when resection is indicated, the following issues must be considered ; direct invasion around the pancreas, lymph node metastasis and tumor spreading in the pancreatic duct. A pancreatectomy with lymph node dissection should be performed if the potential exists for extrapancreatic invasion. Limited pancreatic resection has a role in non-invasive IPMN treatment if extrapancreatic invasion has been ruled out preoperatively, or if a negative pancreatic cut end margin has been obtained during surgery. However, limited pancreatic resection is associated with numerous problems, including technical difficulties. A higher incidence of postoperative complications, including pancreatic fistulae, also exists. | |